Skip to main content
SpringerLink
Log in

Ezetimibe/Simvastatin or Atorvastatin for the Treatment of Hypercholesterolemia in Patients with the Metabolic Syndrome: The VYMET Study

  • Clinical Trial Report
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group [no authors listed]. N Engl J Med 1998, 339:1349–1357.

  2. Cannon C, Braunwald E, McCabe C, et al.: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004, 350:1495–1504.

    Article  CAS  PubMed  Google Scholar 

  3. Conard SE, Bays HE, Leiter LA, et al.: Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease. Am J Cardiol 2008, 102:1489–1494.

    Article  CAS  PubMed  Google Scholar 

  4. Leiter LA, Bays H, Conard S, et al.: Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease. Am J Cardiol 2008, 102:1495–1501.

    Article  CAS  PubMed  Google Scholar 

  5. Kastelein JJ, Akdim F, Stroes ES, et al.: Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008, 358:1431–1443.

    Article  CAS  PubMed  Google Scholar 

  6. Taylor AJ, Villines TC, Stanek EJ, et al.: Extended-release niacin or ezetimibe and carotid intima-thickness. N Engl J Med 2009, 361:2113–2122.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Diabetes and Metabolism Translational Medicine Unit, Colchester Research Facility 110C, University of Vermont College of Medicine, 208 South Park Street, Colchester, VT, 05446, USA

    Jennifer Villa & Richard E. Pratley

Authors
  1. Jennifer Villa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard E. Pratley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard E. Pratley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Villa, J., Pratley, R.E. Ezetimibe/Simvastatin or Atorvastatin for the Treatment of Hypercholesterolemia in Patients with the Metabolic Syndrome: The VYMET Study. Curr Diab Rep 10, 173–175 (2010). https://doi.org/10.1007/s11892-010-0107-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-010-0107-5

Keywords

Search

Navigation